Indian Sucrose (BSE 500319)₹72.89−0.40%Sugar
In the Mar 2026 quarter (standalone), Indian Sucrose reported sales of ₹309 Cr, down 1.3% from Mar 2025, and net profit of ₹25.89 Cr, down 27.8% year on year. For the year to Mar 2026, sales were ₹512 Cr and net profit ₹30.87 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 111 | 91.30 | 66.26 | 262 | 124 | 57.23 | 52.18 | 313 | 84.26 | 39.13 | 80.21 | 309 |
| Expenses | 102 | 88.82 | 56.89 | 212 | 113 | 56.85 | 44.94 | 257 | 74.87 | 37.90 | 68.88 | 249 |
| Operating Profit | 9.01 | 2.01 | 9.01 | 49.06 | 12.02 | 0.00 | 7.01 | 54.10 | 8.01 | 1.01 | 11.01 | 58.03 |
| OPM % | 8.0% | 2.3% | 14.0% | 19.0% | 10.0% | −0.5% | 14.0% | 17.0% | 10.0% | 2.7% | 14.0% | 19.0% |
| Other Income | 4.01 | 2.01 | 3.01 | 4.01 | 2.01 | 4.01 | 5.02 | 4.01 | 2.01 | 4.01 | 4.01 | −11.03 |
| Interest | 6.98 | 6.98 | 5.98 | 6.98 | 6.98 | 5.98 | 5.98 | 5.98 | 5.98 | 5.98 | 4.98 | 5.98 |
| Depreciation | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 1.99 | 2.99 | 2.99 | 1.99 | 2.99 | 2.99 | 3.99 |
| Profit before tax | 4.01 | −5.02 | 3.01 | 43.09 | 4.01 | −4.01 | 4.01 | 49.16 | 3.01 | −3.01 | 7.01 | 37.11 |
| Tax % | 54.1% | −47.9% | 38.1% | 26.1% | 25.1% | −24.9% | 26.1% | 27.1% | 25.1% | 18.1% | 9.1% | 29.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −12.16 |
| Net Profit | 1.99 | −2.99 | 1.99 | 31.90 | 2.99 | −2.99 | 2.99 | 35.86 | 1.99 | −3.99 | 6.97 | 25.89 |
| EPS (Rs) | 0.97 | −1.61 | 1.00 | 18.48 | 1.62 | −1.90 | 1.64 | 20.71 | 1.14 | −2.10 | 3.86 | 15.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 284 | 387 | 421 | 364 | 534 | 432 | 445 | 453 | 530 | 548 | 512 | 512 |
| Expenses | 249 | 320 | 382 | 309 | 480 | 377 | 384 | 386 | 458 | 471 | 431 | 431 |
| Operating Profit | 34.05 | 65.02 | 36.06 | 52.02 | 51.04 | 53.06 | 59.08 | 65.11 | 69.08 | 73.13 | 79.03 | 78.06 |
| OPM % | 12.0% | 17.0% | 9.0% | 14.0% | 10.0% | 12.0% | 13.0% | 14.0% | 13.0% | 13.0% | 15.0% | 15.2% |
| Other Income | 1.01 | 6.02 | −2.01 | −15.05 | 2.01 | 4.01 | 7.02 | 11.04 | 13.04 | 15.05 | 0.00 | −1.00 |
| Interest | 17.95 | 18.96 | 13.97 | 20.93 | 24.94 | 17.94 | 18.94 | 24.93 | 26.93 | 24.91 | 22.94 | 22.92 |
| Depreciation | 7.98 | 6.98 | 6.98 | 7.98 | 7.98 | 7.98 | 6.98 | 7.98 | 10.98 | 10.97 | 11.97 | 11.96 |
| Profit before tax | 8.02 | 45.09 | 13.04 | 8.02 | 19.04 | 31.06 | 40.13 | 42.13 | 44.09 | 53.18 | 43.13 | 44.12 |
| Tax % | 22.1% | 33.0% | 37.1% | 46.1% | 36.1% | 27.1% | 8.0% | 29.1% | 26.1% | 27.1% | 28.1% | — |
| Exceptional items | 0.00 | 0.10 | −5.04 | −15.00 | 0.00 | 0.00 | 0.00 | −0.01 | −0.15 | −0.14 | −12.19 | −12.16 |
| Net Profit | 5.98 | 29.89 | 7.97 | 3.99 | 11.95 | 21.93 | 36.86 | 29.91 | 32.90 | 37.86 | 30.87 | 30.86 |
| EPS (Rs) | 3.85 | 19.30 | 5.42 | 2.83 | 7.93 | 14.46 | 21.87 | 17.26 | 18.85 | 22.08 | 17.88 | 17.90 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.98 | 14.99 | 14.98 | 14.98 | 14.99 | 14.98 | 14.98 | 16.99 | 16.98 | 16.98 | 17.01 | 16.99 |
| Reserves | 29.09 | 35.11 | 71.27 | 75.20 | 70.20 | 74.26 | 95.28 | 135 | 165 | 198 | 241 | 276 |
| Borrowings | 196 | 231 | 236 | 226 | 180 | 153 | 204 | 181 | 224 | 208 | 211 | 192 |
| Other Liabilities | 71.26 | 50.24 | 63.18 | 104 | 213 | 212 | 176 | 173 | 174 | 166 | 185 | 149 |
| Total Liabilities | 311 | 331 | 387 | 421 | 479 | 454 | 491 | 507 | 581 | 590 | 656 | 633 |
| Fixed Assets | 82.89 | 76.91 | 73.84 | 107 | 108 | 106 | 102 | 99.76 | 204 | 203 | 198 | 193 |
| CWIP | 0.00 | 0.00 | 0.00 | 20.99 | 24.99 | 34.98 | 60.01 | 90.92 | 0.99 | 1.99 | 1.99 | 1.99 |
| Investments | 1.99 | 1.99 | 7.97 | 7.96 | 2.99 | 1.99 | 0.99 | 0.99 | 0.00 | 0.00 | 6.97 | 10.96 |
| Other Assets | 227 | 252 | 305 | 285 | 343 | 310 | 328 | 314 | 375 | 385 | 449 | 427 |
| Inventories | 154 | 164 | 192 | 174 | 240 | 214 | 191 | 189 | 214 | 194 | 159 | 150 |
| Trade receivables | 6.99 | 13.99 | 15.97 | 21.96 | 37.92 | 49.94 | 73.88 | 72.92 | 53.89 | 67.93 | 121 | 161 |
| Cash & equivalents | 22.06 | 49.18 | 21.08 | 14.04 | 14.05 | 17.05 | 27.07 | 20.07 | 32.13 | 20.06 | 145 | 90.27 |
| Total Assets | 311 | 331 | 387 | 421 | 479 | 454 | 491 | 507 | 581 | 590 | 656 | 633 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −84.87 | 28.97 | −32.98 | 86.92 | 34.96 | 155 | −70.92 | 86.98 | 46.99 | 55.97 | 67.97 |
| Cash from investing activity | −2.01 | −2.01 | −9.01 | −70.14 | −10.01 | −35.04 | −22.03 | −36.08 | −54.11 | −29.03 | 81.20 |
| Cash from financing activity | 101 | 1.01 | 18.06 | −24.08 | −24.07 | −122 | 88.35 | −39.12 | 18.07 | −41.14 | −22.07 |
| Net cash flow | 14.02 | 28.04 | −23.04 | −7.01 | 0.00 | −1.01 | −4.01 | 12.01 | 11.01 | −15.02 | 127 |
| Capex | 4.10 | 2.76 | 4.61 | 71.62 | 14.04 | 16.32 | 27.42 | 36.69 | 21.78 | 11.20 | 8.48 |
| Free cash flow | −89.16 | 26.05 | −37.10 | 17.02 | 22.05 | 139 | −98.24 | 50.08 | 25.06 | 45.09 | 62.14 |
| CFO / OP % | −603.0% | 85.0% | −35.0% | 264.0% | 67.0% | 307.0% | −123.0% | 165.0% | 104.0% | 86.0% | 100.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 12 | 18 | 15 | 19 | 38 | 34 | 63 | 60 | 44 | 47 | 81 | 115 |
| Inventory days | 324 | 265 | 238 | 181 | 323 | 190 | 207 | 220 | 242 | 181 | 148 | 150 |
| Days payable | 108 | 37 | 16 | 75 | 247 | 155 | 136 | 149 | 149 | 103 | 118 | 93 |
| Cash conversion cycle | 229 | 248 | 238 | 127 | 115 | 71 | 134 | 132 | 138 | 125 | 112 | 174 |
| Working capital days | −42 | −22 | 27 | −10 | −17 | −6 | −15 | −6 | −5 | 24 | −32 | 26 |
| ROCE % | 2.0% | 10.1% | 21.1% | 11.1% | 19.1% | 17.1% | 17.1% | 18.0% | 18.1% | 17.1% | 17.0% | 17.1% |
For the Mar 2026 quarter, Indian Sucrose reported sales of ₹309 Cr, down 1.3% year on year and net profit of ₹25.89 Cr, down 27.8% year on year. The operating margin was 19.0%.
Indian Sucrose's sales for the year to Mar 2026 were ₹512 Cr; over the last twelve months they were ₹512 Cr.
Net profit for the year to Mar 2026 was ₹30.87 Cr, and ₹30.86 Cr over the last twelve months. Earnings per share over the same trailing period were ₹17.90.
Indian Sucrose reported borrowings of ₹192 Cr at Mar 2026, against cash and equivalents of ₹90.27 Cr.
Cash from operations was ₹67.97 Cr in the year to Mar 2025; after capital spending, free cash flow was ₹62.14 Cr.